• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Teva Pharmaceutical Industries Limited (TEVA)

Common Shares
Sell: $37.22|Buy: $37.40|Change: 0.53 (1.44%)

This share can be held in a Dealing accountSIPP

Key ratios

Company
PER (E)Ratio18.90
Dividend yield (E)Percentage0.00
Price earning growth (E)Ratio1.02
Return on equityPercentage21.23
Operating marginPercentage0.23
Earning per share growth (E)Percentage2.40
Enterprise value/earnings before interest, taxes, depreciation and amortizationMultiple21.62
Price to tangible book valueMultiple5.61
Price/Cash flowMultiple22.88
Price/SalesMultiple2.51

Profitability

Financial health

Growth

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.